FDA Designated Breakthrough Devices-Upcoming Proposal to Expedite Medicare Coverageadmin2022-05-31T17:10:28-07:00
Rowinski Group Awarded National Re-Certification as a Women’s Business Enterpriseadmin2022-02-22T04:11:34-08:00
The University of California-San Francisco (UCSF) Rosenman Institute Program Funding OpportunitySusan Rowinski2021-03-26T14:51:58-07:00
University Licensing Dept Wants to Improve Corporate Transactions, Listens to Payers for Adviceadmin2021-03-31T13:37:25-07:00
Diagnostic Company Uses Reimbursement Data for Regulatory and FDA Planningadmin2021-03-31T13:33:35-07:00
Cardiovascular Start-Up Begins Concurrent Coverage & Reimbursement Planning Early, See Whyadmin2021-03-31T13:31:57-07:00
Digital Therapeutics Company Begins Reimbursement Planning Too Late, Leaving Few Optionsadmin2021-03-31T13:29:06-07:00
Investment Firm Uses Provider Data for Evaluation of the Traumatic Brain Injury Marketadmin2021-03-31T13:25:42-07:00
